NASDAQ Newsroom NASDAQ Investor Relations Listed Companies How our Market Works NASDAQ Corporate www.NASDAQ.com
Nasdaq
Web NASDAQ.com   

Mark Ahn, President & CEO of Hana Biosciences, Inc., Presides Over the Market Close
 

Mark Ahn, President & CEO of Hana Biosciences, Inc., rings The NASDAQ Stock Market Closing Bell

Mark Ahn, President & CEO of Hana Biosciences, Inc., Rings The NASDAQ Stock Market Closing Bell

Thursday, June 29, 2006
at NASDAQ's MarketSite
in New York City.


Hana Biosciences, Inc.

 
Additional Photographs & Reprint Permissions
Archived MarketSite Events | Summary Quote

Mark Ahn, President & CEO of Hana Biosciences, Inc. (HNAB) presides over the closing bell to celebrate its start of trading on NASDAQ.

Hana Biosciences, Inc. (Nasdaq:HNAB) is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to advance cancer care. The company is committed to creating value by building a world-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner of choice, and nurturing a unique company culture. Additional information on Hana Biosciences can be found at www.hanabiosciences.com.




Reprints

Click for larger pictures of the NASDAQ MarketSite.

Additional Photographs for 6/29/2006

© Copyright 2006, The NASDAQ Stock Market, Inc.
Reprinted with the permission of The Nasdaq Stock Market, Inc.